Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Captopril and Asa-404



Research Papers that Mention the Interaction

In a randomized phase II trial in patients (pts) with advanced NSCLC, the vascular disrupting agent ASA404 (vadimezan) in combination with CP was found to improve several efficacy parameters including overall survival (OS).
The addition of ASA404 to CP , although generally well-tolerated, failed to improve efficacy in pts with advanced NSCLC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology  •  2011  |  View Paper